Key result
Maternal SARS-CoV-2 infection can trigger neonatal multisystem inflammatory syndrome via transplacental antibody transfer.
Why the study?
The clinical profile of multisystem inflammatory syndrome in neonates (MIS-N) associated with maternal COVID-19 remains obscure due to lack of published literature.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
May warrant vigilance for MIS-N in neonates of infected mothers; leaves open incidence, outcomes, and management strategies.
Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 is a rare but often life-threatening clinical entity that presents 3-6 weeks after SARS-CoV-2 infection with high fever, organ dysfunction, and strongly elevated markers of inflammation.Unlike MIS-C, where SARS-CoV-2 infection and multisystem inflammation occur in the same subject, maternal SARS-CoV-2 infection may cause a similar hyperinflammatory syndrome in neonates called multisystem inflammatory syndrome in neonates (MIS-N) due to transplacental transfer of antibodies.The clinical profile of these babies remains obscure due to a lack of published literature.Our case highlights the need for practicing pediatricians to be vigilant and to have a high index of clinical suspicion of MIS-N in all critically ill neonates irrespective of antenatal COVID-19 status of mother.
No takes yet. Share an insight, caveat, or question.
Nitya et al. (2022) conducted a case report in Multisystem inflammatory syndrome in neonates (MIS-N) (n=1). Maternal SARS-CoV-2 infection was evaluated. Maternal SARS-CoV-2 infection can cause multisystem inflammatory syndrome in neonates (MIS-N) via transplacental antibody transfer, necessitating high clinical suspicion in critically ill neonates.
Synapse has enriched 10 related papers. Consider them for comparative context: